MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 15, 2006; DOI: 10.1124/mol.105.021659


0026-895X/06/6906-1990-1997$20.00
Mol Pharmacol 69:1990-1997, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021659v1
69/6/1990    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanna, B.
Right arrow Articles by Williams, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanna, B.
Right arrow Articles by Williams, A. J.

The Interaction of an Impermeant Cation with the Sheep Cardiac RyR Channel Alters Ryanoid Association

Bhavna Tanna, William Welch, Luc Ruest, John L. Sutko, and Alan J. Williams

Cardiac Medicine, National Heart & Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, London, United Kingdom (B.T., A.J.W.); Departments of Biochemistry (W.W.) and Pharmacology (J.L.S.), University of Nevada School of Medicine, Reno, Nevada; and Department of Chemistry, University of Sherbrooke, Quebec, Canada (L.R.)

In previous studies, we have demonstrated that the interaction of ryanoids with the sarcoplasmic reticulum Ca2+-release channel [ryanodine receptor (RyR)] incorporated into planar lipid bilayers reduced the effectiveness of tetraethylammonium (TEA+) as a blocker of K+ translocation (J Gen Physiol 117: 385-393, 2001). In the current study, we investigated both the effect of TEA+ on [3H]ryanodine binding and the actions of this impermeant cation on the interaction of the reversible ryanoid 21-amino-9{alpha}-hydroxyryanodine with individual, voltage-clamped RyR channels. A dose-dependent inhibition of [3H]ryanodine binding was observed in the presence of TEA+, suggesting that the cation and alkaloid compete for access to a common site of interaction. Single channel studies gave further insights into the mechanism of the competition between the two classes of ligands. TEA+ decreases the association rate of 21-amino-9{alpha}-hydroxyryanodine with its receptor, whereas the dissociation rate of the ryanoid from the channel was unaffected. Our results demonstrate that TEA+ inhibits both K+ translocation through RyR, and ryanoid interaction at the high affinity ryanodine site on the channel. These actions involve binding of TEA+ to different, but weakly interacting, sites in the RyR channel.


Received December 12, 2005; accepted March 15, 2006

Address correspondence to: Professor Alan J. Williams, Cardiac Medicine, National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, London, SW3 6LY. UK. E-mail: a.j.williams{at}imperial.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics